Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
Drug guidance

Clesrovimab for prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants during their first RSV season

5 October 2026

Condition

Respiratory

-

Published on 05 Oct 2026
Last Updated on 05 Oct 2026

Guidance Recommendations

The Ministry of Health’s Drug Advisory Committee has not recommended clesrovimab for inclusion on the MOH Subsidised Vaccine List (SVL) for prevention of respiratory syncytial virus (RSV)-associated lower respiratory tract disease in infants during their first RSV season. The decision was based on the unfavourable cost effectiveness of clesrovimab compared with no immunisation.

Clesrovimab for prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants during their first RSV season (Published 5 Oct 2026) [PDF, 293.93 KB] (opens in new tab)